AGNC Investment Corp. Dep. Pfd. (Rep. 6.875% Cum. Redeem. Pfd. Series D-0.05% AGNC Investment Corp. Dep. Pfd. (Rep. 1/1000th Pfd. Series C) 0.00% AGNC Investment Corp ...
Rock Springs Capital, Logos Capital, Woodline, and Acuta Capital, amongst others. The cash will be used for further clinical development of Enliven’s two lead candidates, BCR-ABL inhibitor ELVN ...
AGNC Investment Corp. Dep. Pfd. (Rep. 6.875% Cum. Redeem. Pfd. Series D 0.20% AGNC Investment Corp. Dep. Pfd. (Rep. 1/1000th Pfd. Series C)-0.08% AGNC Investment Corp ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...